ESLA short interest
Estrella Immunopharma Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 214,030 |
|---|---|
| Change vs prior report | 60,249 (+39.2%) |
| Change over six months | -65.8% |
| Days to cover | 4.66 (sector: 3.78) |
| Average daily volume | 45,964 |
| Rank in Healthcare | not ranked (OTC, fund or thinly traded) |
ESLA short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 214,030 | +39.2% | 4.66 | 45,964 |
| 2026-09-15 | 153,781 | +31.3% | 4.18 | 36,796 |
| 2026-08-31 | 117,132 | +90.7% | 3.39 | 34,578 |
| 2026-08-14 | 61,410 | +27.8% | 2.62 | 23,447 |
| 2026-07-31 | 48,054 | -11.8% | 1.04 | 46,006 |
| 2026-07-15 | 54,453 | -38.9% | 1.19 | 45,733 |
| 2026-06-30 | 89,082 | -21.4% | 2.45 | 36,369 |
| 2026-06-15 | 113,312 | +37.2% | 2.38 | 47,546 |
| 2026-05-29 | 82,599 | -12.2% | 3.06 | 26,966 |
| 2026-05-15 | 94,135 | -36.2% | 2.67 | 35,197 |
| 2026-04-30 | 147,543 | -44.5% | 3.83 | 38,559 |
| 2026-04-15 | 265,805 | -57.6% | 1.00 | 300,565 |
| 2026-03-31 | 626,324 | -4.5% | 9.85 | 63,557 |
| 2026-03-13 | 656,018 | +2.7% | 16.79 | 39,079 |
| 2026-02-27 | 638,651 | -12.0% | 16.22 | 39,381 |
| 2026-02-13 | 725,979 | -23.1% | 1.00 | 733,653 |
| 2026-01-30 | 943,482 | +9.1% | 12.63 | 74,700 |
| 2026-01-15 | 864,470 | +17.0% | 8.73 | 99,033 |
| 2025-12-31 | 738,819 | +4.2% | 8.63 | 85,654 |
| 2025-12-15 | 709,318 | +28.5% | 4.80 | 147,658 |
| 2025-11-28 | 551,846 | +223.9% | 2.76 | 199,824 |
| 2025-11-14 | 170,374 | +170.4% | 1.00 | 522,149 |
| 2025-10-31 | 63,002 | +112.7% | 1.00 | 455,470 |
| 2025-10-15 | 29,615 | +12.5% | 1.00 | 316,208 |
| 2025-09-30 | 26,333 | -28.2% | 1.00 | 54,859 |
import finzdata as yf
yf.Ticker("ESLA").short_interest # every report since 2017
yf.Client().short_interest(["ESLA"], start="2018-01-01")Healthcare short interest · ESLA price history · Who owns ESLA · All short interest